Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 65Neoplasm Metastasis 14Brain Neoplasms 10Neoplasms 9Endometrial Neoplasms 8Prostatic Neoplasms 7Glioblastoma 7Ovarian Neoplasms 6Triple Negative Breast Neoplasms 5Glioma 5Sarcoma 4Recurrence 3Neoplasms by Site 3Meningioma 3Liposarcoma 3Carcinoma, Non-Small-Cell Lung 3Breast Diseases 3Unilateral Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Osteosarcoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Ependymoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Advanced Breast Cancer 2Venous Thromboembolism 1Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 9Practice Guidelines as Topic 7Standard of Care 6Taxes 4Paclitaxel 4Early Intervention, Educational 4Docetaxel 4pertuzumab 3pembrolizumab 3Trastuzumab 3Methods 3Educational Status 3Biopsy 3trastuzumab biosimilar HLX02 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 22C4 antibody 2regadenoson 1nilotinib 1fisetin 1abemaciclib 1Yoga 1X-Ray Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage I Breast Cancer AJCC v8 × abemaciclib × 1 year × Clear all
NCT07191717 2025-11-10

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Jonsson Comprehensive Cancer Center

Phase 2 Not yet recruiting
42 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡